Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 19 February 1993:
Vol. 259. no. 5098, pp. 1165 - 1169
DOI: 10.1126/science.8267690
Prev | Table of Contents | Next

Articles

Science, Vol 259, Issue 5098, 1165-1169
Copyright © 1993 by American Association for the Advancement of Science

articles

Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors

MA Lipes, A Rosenzweig, KN Tan, G Tanigawa, D Ladd, JG Seidman, and GS Eisenbarth

Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.

The T cell receptor (TCR) requirements in the pathogenesis of insulin-dependent diabetes were examined with transgenic NOD mice bearing nondisease-related TCR alpha and beta chains. In both TCR beta and TCR alpha beta transgenic NOD mice the beta chain transgene was expressed by > 98% of peripheral T cells. The alpha chain transgene was also highly expressed. Insulitis developed in both sets of transgenic animals with most of the lymphocytes in the lesion expressing the transgenic beta chain and with depletion of the endogenous TCR V beta genes. Nonetheless, NOD animals transgenic for TCR beta and TCR alpha beta developed diabetes similar to controls. Thus, skewing the TCR repertoire did not diminish autoimmune susceptibility in NOD mice.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Transgenic Insulin (B:9-23) T-Cell Receptor Mice Develop Autoimmune Diabetes Dependent Upon RAG Genotype, H-2g7 Homozygosity, and Insulin 2 Gene Knockout..
J. M. Jasinski, L. Yu, M. Nakayama, M. M. Li, M. A. Lipes, G. S. Eisenbarth, and E. Liu (2006)
Diabetes 55, 1978-1984
   Abstract »    Full Text »    PDF »
Expression of the B7.1 Costimulatory Molecule on Pancreatic {beta} Cells Abrogates the Requirement for CD4 T Cells in the Development of Type 1 Diabetes.
E. Havari, A. M. Lennon-Dumenil, L. Klein, D. Neely, J. A. Taylor, M. F. McInerney, K. W. Wucherpfennig, and M. A. Lipes (2004)
J. Immunol. 173, 787-796
   Abstract »    Full Text »    PDF »
CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer.
K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt (2002)
J. Exp. Med. 196, 481-492
   Abstract »    Full Text »    PDF »
Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand From a Greatly Reduced Precursor Pool.
D. V. Serreze, E. A. Johnson, H. D. Chapman, R. T. Graser, M. P. Marron, T. P. DiLorenzo, P. Silveira, Y. Yoshimura, S. G. Nathenson, and S. Joyce (2001)
Diabetes 50, 1992-2000
   Abstract »    Full Text »    PDF »
Thymic and Postthymic Regulation of Diabetogenic CD8 T Cell Development in TCR Transgenic Nonobese Diabetic (NOD) Mice.
O. Kanagawa, J. Shimizu, and B. A. Vaupel (2000)
J. Immunol. 164, 5466-5473
   Abstract »    Full Text »    PDF »
Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice.
D. KOYA, J. W. DENNIS, C. E. WARREN, N. TAKAHARA, F. J. SCHOEN, Y. NISHIO, T. NAKAJIMA, M. A. LIPES, and G. L. KING (1999)
FASEB J 13, 2329-2337
   Abstract »    Full Text »
Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy.
H. Wakasaki, D. Koya, F. J. Schoen, M. R. Jirousek, D. K. Ways, B. D. Hoit, R. A. Walsh, and G. L. King (1997)
PNAS 94, 9320-9325
   Abstract »    Full Text »    PDF »
Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets.
R. H. Slover and G. S. Eisenbarth (1997)
Endocr. Rev. 18, 241-258
   Abstract »    Full Text »
T cell receptor restriction of diabetogenic autoimmune NOD T cells.
E. Simone, D. Daniel, N. Schloot, P. Gottlieb, S. Babu, E. Kawasaki, D. Wegmann, and G. S. Eisenbarth (1997)
PNAS 94, 2518-2521
   Abstract »    Full Text »    PDF »
Characterization of a Single-chain Antibody to the beta-Chain of the T Cell Receptor.
B. K. Cho, B. A. Schodin, and D. M. Kranz (1995)
J. Biol. Chem. 270, 25819-25826
   Abstract »    Full Text »    PDF »
T cell receptor specificity and diabetes in nonobese diabetic mice.
D Mathis and C Benoist (1993)
Science 262, 1583
   PDF »
Response.
M. A. Lipes, A. Rosenzweig, K.-N. Tan, G. Tanigawa, J. G. Seidman, and G. S. Eisenbarth (1993)
Science 262, 1584
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)